These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9714750)

  • 1. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart.
    Halestrap AP; Kerr PM; Javadov S; Woodfield KY
    Biochim Biophys Acta; 1998 Aug; 1366(1-2):79-94. PubMed ID: 9714750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury.
    Halestrap AP; Connern CP; Griffiths EJ; Kerr PM
    Mol Cell Biochem; 1997 Sep; 174(1-2):167-72. PubMed ID: 9309682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury.
    Halestrap AP
    Biochem Soc Symp; 1999; 66():181-203. PubMed ID: 10989667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition.
    Javadov SA; Lim KH; Kerr PM; Suleiman MS; Angelini GD; Halestrap AP
    Cardiovasc Res; 2000 Jan; 45(2):360-9. PubMed ID: 10728356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase.
    Halestrap AP; Woodfield KY; Connern CP
    J Biol Chem; 1997 Feb; 272(6):3346-54. PubMed ID: 9013575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase.
    Halestrap AP; Davidson AM
    Biochem J; 1990 May; 268(1):153-60. PubMed ID: 2160810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death.
    Halestrap AP; Brenner C
    Curr Med Chem; 2003 Aug; 10(16):1507-25. PubMed ID: 12871123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore.
    Leung AW; Halestrap AP
    Biochim Biophys Acta; 2008; 1777(7-8):946-52. PubMed ID: 18407825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the mitochondrial membrane permeability transition in cell death.
    Tsujimoto Y; Shimizu S
    Apoptosis; 2007 May; 12(5):835-40. PubMed ID: 17136322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore.
    McStay GP; Clarke SJ; Halestrap AP
    Biochem J; 2002 Oct; 367(Pt 2):541-8. PubMed ID: 12149099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adenosine nucleotide translocase (ANT) proline isomerization on Ca2+-induced cysteine relative mobility/mitochondrial permeability transition pore.
    Pestana CR; Silva CH; Uyemura SA; Santos AC; Curti C
    J Bioenerg Biomembr; 2010 Aug; 42(4):329-35. PubMed ID: 20614171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid binds to and inhibits adenine nucleotide translocase and induces mitochondrial permeability transition.
    Notario B; Zamora M; Viñas O; Mampel T
    Mol Pharmacol; 2003 Jan; 63(1):224-31. PubMed ID: 12488555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mitochondrial membrane bound-glutathione transferase by mitochondrial permeability transition inhibitors including cyclosporin A.
    Ulziikhishig E; Lee KK; Hossain QS; Higa Y; Imaizumi N; Aniya Y
    Life Sci; 2010 May; 86(19-20):726-32. PubMed ID: 20226794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The permeability transition pore complex: another view.
    Halestrap AP; McStay GP; Clarke SJ
    Biochimie; 2002; 84(2-3):153-66. PubMed ID: 12022946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.
    Leung AW; Varanyuwatana P; Halestrap AP
    J Biol Chem; 2008 Sep; 283(39):26312-23. PubMed ID: 18667415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
    Clarke SJ; McStay GP; Halestrap AP
    J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide administration increases the susceptibility of mitochondrial permeability transition pore opening via altering adenine nucleotide translocase conformation in the mouse liver.
    Nakajima R; Takemura A; Ikeyama Y; Ito K
    J Toxicol Sci; 2023; 48(2):65-73. PubMed ID: 36725022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
    Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
    J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the mitochondrial permeability transition pore in heart disease.
    Halestrap AP; Pasdois P
    Biochim Biophys Acta; 2009 Nov; 1787(11):1402-15. PubMed ID: 19168026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury.
    Argaud L; Gateau-Roesch O; Muntean D; Chalabreysse L; Loufouat J; Robert D; Ovize M
    J Mol Cell Cardiol; 2005 Feb; 38(2):367-74. PubMed ID: 15698843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.